Most Clicked StoriesMore >


Review examines skin cancer risk after stem cell transplant

AABB SmartBrief | Apr 24, 2015

A review of 18 studies found that patients who had hematopoietic cell transplants were more likely to develop cutaneous malignant neoplasms, researchers reported in the journal JAMA Dermatology. Squamous cell carcinoma, basal cell carcinoma and melanoma were the most commonly reported malignancies. Healio (free registration) (04/23)


Study assesses gene therapy for Wiskott-Aldrich syndrome

AABB SmartBrief | Apr 22, 2015

Study examines stem cell treatment for amyotrophic lateral sclerosis

AABB SmartBrief | Apr 22, 2015

Study ties hepatitis C infection to higher risk of nonliver cancers

AABB SmartBrief | Apr 27, 2015

Researchers genetically modify beta-thalassemia gene in human embryos

AABB SmartBrief | Apr 23, 2015

AABB CareerLink matches candidates with jobs in patient blood management, transfusion medicine and cellular therapies

AABB SmartBrief | Apr 24, 2015

Study identifies drug to reactivate latent cytomegalovirus

AABB SmartBrief | Apr 24, 2015

Abraham Verghese chosen as keynote speaker for AABB 2015 Annual Meeting

AABB SmartBrief | Apr 21, 2015

New AABB Standards Portal provides customized standards

AABB SmartBrief | Apr 22, 2015

Study examines blood test for guiding treatment of colorectal cancer

AABB SmartBrief | Apr 24, 2015


Find AABB SmartBrief Issues by Date:



AABB News More >


Reminder: Comments on proposed standards for RT Laboratories due today, April 27

AABB SmartBrief | Apr 27, 2015

AABB CareerLink matches candidates with jobs in patient blood management, transfusion medicine and cellular therapies

AABB SmartBrief | Apr 24, 2015

Reminder: Register for AABB's symposium on pathogen-reduced blood products

AABB SmartBrief | Apr 23, 2015

New AABB Standards Portal provides customized standards

AABB SmartBrief | Apr 22, 2015

Abraham Verghese chosen as keynote speaker for AABB 2015 Annual Meeting

AABB SmartBrief | Apr 21, 2015




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more